BRIEF-AnPac Bio Class III Medical Device Passes Extensive NMPA Registration Tests
* ANPAC BIO CLASS III MEDICAL DEVICE PASSES EXTENSIVE NMPA REGISTRATION TESTS AND WILL START CLINICAL TRIAL IN Q1, 2022 Source text for Eikon: Further company coverage: